Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03988543 · ClinicalTrials.gov registry record · NA
Bilingual Electronic Symptom Management Program Across Multi-site, Comprehensive Cancer Center
A NA study of Cancer, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 4,104
- Enrollment target
- 1
- Study location
NCT03988543: Completed NA study of Cancer, sponsored by Northwestern University.
NCT03988543 is a NA study of Cancer that has completed, run by Northwestern University. The registered enrollment target is 4,104 participants, above the 3,484-participant average among 615 other Cancer trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03988543, a NA study of Cancer, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,104 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer, and cancer treatment, cause many symptoms that can negatively affect quality of life. Despite the development of improved symptom management interventions and several evidence- and consensus-based guidelines, their timely delivery remains uneven in the health care system. Our research center, Northwestern University IMPACT (NU IMPACT), builds upon an electronic health record (EHR)-integrated cancer symptom monitoring and management system, currently deployed by our health care system. We are testing the effectiveness of a system-wide symptom management intervention and the EHR-integrated enhanced care approach, which offers a more personalized symptom monitoring and management experience based on a person's unique needs and language (i.e., English or Spanish).
Primary Outcome
Symptom severity will be assessed using Patient-Reported Outcomes Measurement Information System (PROMIS) computer adaptive tests (CATs) related to symptoms of pain, fatigue, depression, anxiety, and physical function. CAT question items are dynamically selected for administration from an item bank based upon the respondent's previous answers. Patient usually completes 4-12 items with a high level of measurement precision for each domain.
Conditions Studied
Interventions
- BEHAVIORAL Patient Self-management
Study Locations (1)
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,104 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2024-05-15 |
| Phase | NA |
What the finished NCT03988543 record still lists
NCT03988543 is an interventional study that assigns participants to a tested intervention. Its 4,104 participants enrollment target places it among the larger protocols in the corpus, above the 3,484-participant average among 615 other Cancer trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient Self-management is the first listed.
NCT03988543 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03988543 about?
NCT03988543 is a clinical study titled "Bilingual Electronic Symptom Management Program Across Multi-site, Comprehensive Cancer Center". Cancer, and cancer treatment, cause many symptoms that can negatively affect quality of life. Despite the development of improved symptom management interventions and several evidence- and consensus-based guidelines, their timely delivery remains uneven in the health care system. Our research center...
What is the current status of trial NCT03988543?
This trial is currently completed. It is a NA study. The enrollment target is 4,104 participants. The study started on 2020-09-28. Estimated completion is 2024-05-15.
What conditions does trial NCT03988543 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT03988543?
The interventions under investigation include: Patient Self-management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03988543?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03988543 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03988543's enrollment target sits among peer trials
4,104 46th of 615 higher than 570 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03388606 · 4,100 participants
Characterization and Treatment of Adolescent Depression
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI